KZIA
KZIA clinical trials: KAZIA THERAPEUTICS LTD
Every trial on ClinicalTrials.gov where KAZIA THERAPEUTICS LTD is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 14
- Trials linked
- 5
- As lead sponsor
- 9
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
KZIA on the catalyst calendar · KZIA registry changes
- Primary completion Nov 4, 2024ActualPhase 1NCT05114668Safety, Tolerability, and Pharmacokinetics of EVT801 in Patients With Advanced Solid TumoursKazia Therapeutics Limited · Solid Tumor, AdultCompletedKZIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 30, 2023ActualPhase 2NCT03522298Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed GlioblastomaKazia Therapeutics Limited · Glioblastoma, AdultCompletedKZIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 24, 2020ActualPhase 1NCT02903771Phase I Study of Cantrixil in Patients With Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer.Kazia Therapeutics Limited · Ovarian NeoplasmsCompletedKZIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 30, 2023ActualPhase 1NCT05012670Mass Balance Recovery, Metabolite Profile, and Metabolite Identification of [14C]-Paxalisib in Healthy Male SubjectsKazia Therapeutics Limited · HealthyCompletedKZIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Not registeredPhase 1NCT00022295Phenoxodiol in Treating Patients With Refractory Solid TumorsKazia Therapeutics Limited · Unspecified Adult Solid Tumor, Protocol SpecificCompletedKZIALead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 13, 2025ActualPhase 2NCT03994796Genetic Testing in Guiding Treatment for Patients With Brain MetastasesAlliance for Clinical Trials in Oncology · CDK Gene MutationActive, not recruitingKZIACollaboratorLLYCollaboratorBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2028Sponsor estimatePhase 2/Phase 3NCT03970447A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaGlobal Coalition for Adaptive Research · Glioblastoma
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 10, 2026ActualPhase 2NCT05183204Paxalisib With a High Fat, Low Carb Diet and Metformin for GlioblastomaWeill Medical College of Cornell University · GlioblastomaCompletedKZIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2026Sponsor estimatePhase 2NCT04906096Paxalisib (GDC-0084) In Recurrent Or Refractory PCNSLLakshmi Nayak, MD · Primary Central Nervous System LymphomaRecruitingKZIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 29, 2024ActualPhase 2NCT03765983GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain MetastasesDana-Farber Cancer Institute · Breast CancerTerminatedKZIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 1NCT04192981GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal MetastasesMemorial Sloan Kettering Cancer Center · Brain MetastasesActive, not recruitingKZIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 19, 2029Sponsor estimatePhase 1/Phase 2NCT073912155G-PEARL: Paxalisib in Malignant Brain TumoursInstitute of Cancer Research, United Kingdom · Malignant Primary GliomasRecruitingKZIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2030Sponsor estimatePhase 1/Phase 2NCT06208657Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent CancerAustralian & New Zealand Children's Haematology/Oncology Group · Childhood CancerRecruitingKZIACollaboratorBMYCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2, 2021ActualPhase 1NCT03696355Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline GliomasSt. Jude Children's Research Hospital · Brain and Central Nervous System TumorsCompletedKZIACollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 14 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner